跳至主要内容
临床试验/IRCT2015101924597N1
IRCT2015101924597N1已完成2 期

The effect of spironolactone on the clinical characteristics, laboratory, and echocardiography in patients with heart failure Preserved EF

Vice chancellor for research of Iran university of medical sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Patients have a clear history of heart failure, according to Framingham criteria (the two major criteria or a major criteria and two minor criteria); Transthoracic Echocardiography with an Ejection Fraction(EF) more than or equal to 45%; and based on the criteria in the class New York Heart Association(NYHA) III and IV and have need to admition in Intesive Care Unit(ICU). Exclusion criteria: serum creatinine > 2.5 mgr/dlit in males and > 2 mgr/dlit in females or GFR < 30ml/min/1.73 m2; serum potassium> 5.5 mEq/L.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research of Iran university of medical sciences

相似试验